Search

CET and skills guides

Study and gain CET points through OT’s online CET exams, and access archived CET, CPD articles and skills guides in our education library

Find out more

Science and vision

News and features about the latest scientific developments and advances in optometry, ophthalmology and eye medicine

Find out more

Professional support

News and features about the latest developments relating to professional support from across optics. This includes updates from optical organisations such as the AOP and the GOC

Find out more

Jobs

Explore the latest UK and global jobs in the optical sector for optometrists, dispensing opticians and more

Find out more

Johnson & Johnson Vision and Menicon join forces in myopia management

Through the strategic collaboration, the companies aim to expand the availability of Menicon products developed to manage the progression of myopia

child on swing
Pexels/Skitterphoto

Johnson & Johnson Vision and contact lens manufacturer Menicon have announced a global strategic collaboration to expand the availability of therapeutic contact lenses to manage the progression of myopia in children.

Through the collaboration, Menicon will develop and manufacture contact lenses to help manage the progression of myopia in children. Meanwhile, Johnson & Johnson Vision will work to expand the availability of the lenses around the world.

The agreement follows a number of steps taken by each company to address the rise in myopia. In 2019, Menicon launched its Menicon Bloom Myopia Control Management System in Europe.

This year, Johnson & Johnson Vision released its myopia management guide, sharing recommendations for eye care professionals.

Dr Hidenari Tanaka, president at Menicon, said the partnership represented a “wonderful opportunity to expand and realise our potential to effectively address the progression of myopia in children worldwide.”

Global president for Johnson & Johnson Vision Care, Peter Menziuso, also commented that the collaboration marked a “step forward” for the company in its aim to offer a portfolio of products to help manage myopia.

The companies highlighted the long-term threats associated with myopia, with half of the world’s population projected to be myopic by 2050 and one billion people expected to have high myopia (Holden et al, Ophthalmology 2016; 123: 1036).

Professor Ian Flitcroft, ophthalmologist and consultant of Johnson & Johnson Vision, commented: “As eye care practitioners we see the long-term impact when myopia progresses or worsens, which can lead to other eye disease and even loss of vision.

“There is no safe level of myopia and there is an emerging need for more myopia treatment options, with an even greater need for industry, eye care providers, and parents to collaborate and help stop the progression of myopia in children.”